AAAAAA

   
Results: 1-20 |
Results: 20
EBV-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN T-CELLDEPLETED BONE-MARROW TRANSPLANT (BMT) PATIENTS
Authors: KING R ARGANI P PAPADOPOULOS EB OREILLY RJ LADANYI M FILIPPA DA
Citation: R. King et al., EBV-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN T-CELLDEPLETED BONE-MARROW TRANSPLANT (BMT) PATIENTS, Modern pathology, 11(1), 1998, pp. 134-134
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE
Authors: PAPADOPOULOS EB CARABASI MH CASTROMALASPINA H CHILDS BH MACKINNON S BOULAD F GILLIO AP KERNAN NA SMALL TN SZABOLCS P TAYLOR J YAHALOM J COLLINS NH BLEAU SA BLACK PM HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE, Blood, 91(3), 1998, pp. 1083-1090
RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS
Authors: MICHEL G BOULAD F SMALL TN BLACK P HELLER G CASTROMALASPINA H CHILDS BH GILLIO AP PAPADOPOULOS EB YOUNG JW KERNAN NA OREILLY RJ
Citation: G. Michel et al., RISK OF EXTRAMEDULLARY RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA WITH LEUKEMIA-CUTIS, Bone marrow transplantation, 20(2), 1997, pp. 107-112
2ND ALLOGENEIC BONE-MARROW TRANSPLANT [BMT] FOR RELAPSED DISEASE OR SECONDARY MALIGNANCIES
Authors: CHILDS BH BOULAD F CASTROMALASPINA H GEORGE D JAKUBOWSKI A KERNAN NA PAPADOPOULOS EB SMALL TN YOUNG JW BLACK P OREILLY RJ
Citation: Bh. Childs et al., 2ND ALLOGENEIC BONE-MARROW TRANSPLANT [BMT] FOR RELAPSED DISEASE OR SECONDARY MALIGNANCIES, Blood, 90(10), 1997, pp. 2452-2452
HUMAN EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTES HOME PREFERENTIALLY TO AND INDUCE SELECTIVE REGRESSIONS OF AUTOLOGOUS EBV-INDUCED B-CELL LYMPHOPROLIFERATIONS IN XENOGRAFTED C.B-17 SCID SCID MICE/
Authors: LACERDA JF LADANYI M LOUIE DC FERNANDEZ JM PAPADOPOULOS EB OREILLY RJ
Citation: Jf. Lacerda et al., HUMAN EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTES HOME PREFERENTIALLY TO AND INDUCE SELECTIVE REGRESSIONS OF AUTOLOGOUS EBV-INDUCED B-CELL LYMPHOPROLIFERATIONS IN XENOGRAFTED C.B-17 SCID SCID MICE/, The Journal of experimental medicine, 183(3), 1996, pp. 1215-1228
CURRENT RESULTS OF DONOR LEUKOCYTE INFUSIONS (DLI) FOR TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS (EBVLPD) FOLLOWING RELATED AND UNRELATED T-CELL DEPLETED BONE-MARROW TRANSPLANT (TCDBMT)
Authors: PAPADOPOULOS EB SMALL T LADANYI M BOULAD F CASTROMALASPINA H CHILDS B KERNAN N MACKINNON S SZABOLCS P YOUNG J OREILLY RJ
Citation: Eb. Papadopoulos et al., CURRENT RESULTS OF DONOR LEUKOCYTE INFUSIONS (DLI) FOR TREATMENT OF EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS (EBVLPD) FOLLOWING RELATED AND UNRELATED T-CELL DEPLETED BONE-MARROW TRANSPLANT (TCDBMT), Blood, 88(10), 1996, pp. 2712-2712
ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE, Bone marrow transplantation, 15(4), 1995, pp. 591-594
TONSIL LYMPHOMA PRESENTING AS TONSILLITIS AFTER BONE-MARROW TRANSPLANTATION
Authors: YELLIN SA WEISS MH KRAUS DH PAPADOPOULOS EB
Citation: Sa. Yellin et al., TONSIL LYMPHOMA PRESENTING AS TONSILLITIS AFTER BONE-MARROW TRANSPLANTATION, Otolaryngology and head and neck surgery, 112(4), 1995, pp. 544-548
MYCOBACTERIUM-HAEMOPHILUM INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: WHITE MH PAPADOPOULOS EB SMALL TN KIEHN TE ARMSTRONG D
Citation: Mh. White et al., MYCOBACTERIUM-HAEMOPHILUM INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS, Transplantation, 60(9), 1995, pp. 957-960
RADIOLABELED ANTI-CD33 MONOCLONAL-ANTIBODY M195 FOR MYELOID LEUKEMIAS
Authors: JURCIC JG CARON PC NIKULA TK PAPADOPOULOS EB FINN RD GANSOW OA MILLER WH GEERLINGS MW WARRELL RP LARSON SM SCHEINBERG DA
Citation: Jg. Jurcic et al., RADIOLABELED ANTI-CD33 MONOCLONAL-ANTIBODY M195 FOR MYELOID LEUKEMIAS, Cancer research, 55(23), 1995, pp. 5908-5910
ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS BH GILLIO AP KERNAN NA SMALL TN YOUNG JW OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE, Blood, 86(4), 1995, pp. 1261-1268
LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS
Authors: CARABASI MH COLLINS NH SMALL TN CASTROMALASPINA H CHILDS BH MACKINNON S PAPADOPOULOS EB YOUNG JW LEBKOWSKI J OKARMA T VANHOEF M BLACK P OREILLY R
Citation: Mh. Carabasi et al., LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS, Blood, 86(10), 1995, pp. 366-366
IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML
Authors: CARABASI MH CASTROMALASPINA H CHILDS BH PAPADOPOULOS EB YOUNG JW COLLINS NH BLACK P OREILLY RJ
Citation: Mh. Carabasi et al., IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML, Blood, 86(10), 1995, pp. 2246-2246
DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY, Blood, 86(10), 1995, pp. 2251-2251
DONOR T-CELLS TO TREAT EBV-ASSOCIATED LYMPHOMA - REPLY
Authors: PAPADOPOULOS EB OREILLY RJ
Citation: Eb. Papadopoulos et Rj. Oreilly, DONOR T-CELLS TO TREAT EBV-ASSOCIATED LYMPHOMA - REPLY, The New England journal of medicine, 331(10), 1994, pp. 680-680
INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: PAPADOPOULOS EB LADANYI M EMANUEL D MACKINNON S BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH GILLIO AP SMALL TN YOUNG JW KERNAN NA OREILLY RJ
Citation: Eb. Papadopoulos et al., INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 330(17), 1994, pp. 1185-1191
IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION
Authors: PAPADOPOULOS EB BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH COLLINS NH EMANUEL D GILLIO AP KERNAN NA MACKINNON S SMALL TN LINDSLEY K YAHALOM J BLEAU S BLACK P HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION, Blood, 84(10), 1994, pp. 10000331-10000331
ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000538-10000538
RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANT FOLLOWING 131I-M195 BUSULFAN/CYCLOPHOSPHAMIDE (BU/CY) IN PATIENTS WITH ADVANCED/REFRACTORY MYELOID MALIGNANCIES/
Authors: PAPADOPOULOS EB CARON P CASTROMALASPINA H CHILDS B MACKINNON S YOUNG JW JURCIC J FINN R LARSON S OREILLY RJ SCHEINBERG DA
Citation: Eb. Papadopoulos et al., RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANT FOLLOWING 131I-M195 BUSULFAN/CYCLOPHOSPHAMIDE (BU/CY) IN PATIENTS WITH ADVANCED/REFRACTORY MYELOID MALIGNANCIES/, Blood, 82(10), 1993, pp. 10000080-10000080
DONOR LEUKOCYTE INFUSIONS AS TREATMENT OF EPSTEIN-BARR-VIRUS LYMPHOPROLIFERATIVE DISORDERS (EBV-LPD) IN RECIPIENTS OF UNRELATED AND RELATEDALLOGENEIC TRANSPLANTS
Authors: PAPADOPOULOS EB LADANYI M
Citation: Eb. Papadopoulos et M. Ladanyi, DONOR LEUKOCYTE INFUSIONS AS TREATMENT OF EPSTEIN-BARR-VIRUS LYMPHOPROLIFERATIVE DISORDERS (EBV-LPD) IN RECIPIENTS OF UNRELATED AND RELATEDALLOGENEIC TRANSPLANTS, Blood, 82(10), 1993, pp. 10000214-10000214
Risultati: 1-20 |